There is no scientific proof that people suffering from depression can benefit from taking reboxetine. However, clinical trials do provide proof of benefit of bupropion XL and mirtazapine: both agents can alleviate symptoms. This is the conclusion of the final report of the Institute for Quality and Efficiency in Health Care (IQWiG) published on 24 November 2009.
Popularity: unranked [?]
Related posts:
Comments
No Responses to “Antidepressants: Benefit Of Reboxetine Not Proven”